Powered by Partnership
Actively pursuing partnerships with public and private corporations across the nation and globe, the NextGen Institute is forging new relationships and expanding existing collaborations.
Alliance for Precision Health
A world leader in medical technology, we are proud to work with Healthineers on the crucial task of developing new precision health care solutions for the world.
Announced in 2019, Healthineers and the University of Missouri have embarked on a 10-year, $113 million alliance, cementing the largest long-term partnership in Siemens’ history. This momentous agreement will ensure our NextGen researchers and health care partners have unparalleled access to leading-edge diagnostic and therapeutic equipment for years to come.
The impacts of the alliance will be felt across the state and nation. Healthineers expertise will optimize operations within MU Health Care’s hospitals and clinics through digital health tools that will give clinicians access to timely, meaningful, actionable data.
The historic partnership will advance education and continue workforce development in the state, through co-developed curricula in cybersecurity, data science, machine learning and artificial intelligence related to health care.
NAVIFY™ Tumor Board
At MU Health Care’s Ellis Fischel Cancer Center, teams of specialists regularly meet to discuss new or challenging cases at meetings known as tumor boards. Such boards, however, require time-intensive organization of patient information, including radiology and microscope slide images, pathology reports, electronic medical records and more.
Now, the MU School of Medicine is collaborating with leading pharmaceutical and diagnostics company Roche, to streamline and standardize the process so that more patients can benefit from personalized health care from cancer specialists.
MU is the first U.S.-based institution to pilot NAVIFY™ Tumor Board, a software solution that creates a centralized repository of tumor board data. At Ellis Fischel Cancer Center, NAVIFY™ is used for hematology-pathology, ENT, multidisciplinary care, breast cancer and melanoma tumor boards. Plans are underway to use NAVIFY™ at all tumor boards across the cancer center. Early results suggest that the tool creates more time for in-depth discussions on patient care.